Ventricular septal rupture and cardiogenic shock complicating STEMI during COVID-19 pandemic: An old foe re-emerges.
COVID-19
Heart transplant
Mechanical circulatory support
STEMI
VA-ECMO
Ventricular septal rupture
Journal
Heart & lung : the journal of critical care
ISSN: 1527-3288
Titre abrégé: Heart Lung
Pays: United States
ID NLM: 0330057
Informations de publication
Date de publication:
Historique:
received:
21
09
2020
revised:
14
12
2020
accepted:
21
12
2020
pubmed:
3
1
2021
medline:
19
3
2021
entrez:
2
1
2021
Statut:
ppublish
Résumé
The COVID 19 pandemic resulted in a total reduction in the number of hospitalizations for acute coronary syndromes. A consequence of the delay in coronary revascularization has been the resurgence of structural complications of myocardial infarctions. Ventricular septal rupture (VSR) complicating late presenting acute myocardial infarction (AMI) is associated with high mortality despite advances in both surgical repair and perioperative management. Current data suggests a declining mortality with delay in VSR repair; however, these patients may develop cardiogenic shock while waiting for surgery. Available options are limited for patients with VSR who develop right ventricular failure and cardiogenic shock. The survival rate is very low in patients with cardiogenic shock undergoing surgical or percutaneous VSR repair. In this study we present two late presenting ST elevation MI patients who were complicated by rapidly declining hemodynamics and impending organ failure. Both patients were bridged with venoarterial extracorporeal membrane oxygenation (ECMO) to cardiac transplant.
Identifiants
pubmed: 33387761
pii: S0147-9563(20)30476-3
doi: 10.1016/j.hrtlng.2020.12.013
pmc: PMC7756170
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
292-295Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest Ramesh Singh: Baxter: Speaker; Behnam Tehrani: Medtronic: Consulting, speaker; Wayne Batchelor: Abbott: Consulting, speaker; Boston Scientific: consulting; vWave: Consulting. The following authors declare no disclosures or conflict of interest: Hooman Bakhshi, Raghav Gattani, Emmanuel Ekanem, Mehul Desai, Alan M Speir, Shashank Sinha and Matthew W Sherwood.
Références
Eur Heart J. 2009 Jan;30(1):81-8
pubmed: 19036747
Circ Heart Fail. 2019 Jul;12(7):e005981
pubmed: 31296094
Am J Cardiol. 2010 Oct 15;106(8):1095-100
pubmed: 20920645
Heart Lung. 2020 Nov - Dec;49(6):779-782
pubmed: 32980627
Ann Thorac Surg. 2020 Nov 3;:
pubmed: 33157063
JACC Case Rep. 2020 Oct;2(12):2013-2015
pubmed: 32989437
JACC Case Rep. 2020 Aug;2(10):1599-1602
pubmed: 32839758
Heart Lung Circ. 2016 Nov;25(11):1063-1066
pubmed: 27374861
EuroIntervention. 2016 May 17;12(1):94-102
pubmed: 27173869
Eur J Cardiothorac Surg. 2005 Feb;27(2):216-21
pubmed: 15691673
Eur Heart J. 2014 Aug 14;35(31):2060-8
pubmed: 24970335
Can J Cardiol. 2015 Jun;31(6):816-8
pubmed: 25921863
Eur J Heart Fail. 2017 May;19 Suppl 2:97-103
pubmed: 28470920
J Am Coll Cardiol. 2000 Sep;36(3 Suppl A):1110-6
pubmed: 10985713
Ann Thorac Surg. 2012 Aug;94(2):436-43; discussion 443-4
pubmed: 22626761